Regulating pharmaceutical sales visits to doctors slows prescribing of detailed drugs

Most of a group of academic medical centers that imposed restrictions on pharmaceutical sales visits to physicians between 2006 and 2012 saw a significant decrease in prescribing of drugs that are detailed by the drug makers, a new study has found. This was the case for six of eight drug classes included in the analysis, although antipsychotics were one of the two classes where significant decreases were not seen. Study results were published in the May 2 issue of JAMA.

Source: The Brown University Psychopharmacology Update - July 19, 2017 Category: Psychiatry Tags: Industry Trends Source Type: research